BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8673024)

  • 1. Synergistic gene expressions of cyclin E, cdk2, cdk5 and E2F-1 during the prolactin-induced G1/S transition in rat Nb2 pre-T lymphoma cells.
    Hosokawa Y; Yang M; Kaneko S; Tanaka M; Nakashima K
    Biochem Mol Biol Int; 1995 Oct; 37(2):393-9. PubMed ID: 8673024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of E2F1 in mesangial cell proliferation in vitro.
    Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
    Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.
    Iwanaga R; Ohtani K; Hayashi T; Nakamura M
    Oncogene; 2001 Apr; 20(17):2055-67. PubMed ID: 11360190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective repression of growth-regulating cdk2, cyclin E and E2F1 genes in human cell senescence.
    Kanazawa S; Fujiwara Y; Mizuno K
    Kobe J Med Sci; 1994 Dec; 40(5-6):165-74. PubMed ID: 7542356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
    Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.
    Lees E; Faha B; Dulic V; Reed SI; Harlow E
    Genes Dev; 1992 Oct; 6(10):1874-85. PubMed ID: 1398067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activation of cyclin and cyclin-dependent kinase genes by adenovirus E1A12S cDNA product.
    Ishii T; Shimizu M; Kanayama Y; Nakada S; Nojima H; Oda K
    Exp Cell Res; 1993 Oct; 208(2):407-14. PubMed ID: 8375470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of E2F-1 by cyclin A-cdk2.
    Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
    Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
    Hofmann F; Livingston DM
    Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of specific E2F complexes by the v-mos oncogene.
    Afshari CA; Rhodes N; Paules RS; Mudryj M
    Oncogene; 1997 Jun; 14(25):3029-38. PubMed ID: 9223666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity.
    DeGregori J; Leone G; Ohtani K; Miron A; Nevins JR
    Genes Dev; 1995 Dec; 9(23):2873-87. PubMed ID: 7498785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaborative role of E2F transcriptional activity and G1 cyclindependent kinase activity in the induction of S phase.
    Leone G; DeGregori J; Jakoi L; Cook JG; Nevins JR
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6626-31. PubMed ID: 10359762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F1, B-myb and selective members of cyclin/cdk subunits are targets for protein kinase C-mediated bimodal growth regulation in vascular endothelial cells.
    Zhou W; Takuwa N; Kumada M; Takuwa Y
    Biochem Biophys Res Commun; 1994 Feb; 199(1):191-8. PubMed ID: 8123011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdk2-dependent and -independent pathways in E2F-mediated S phase induction.
    Arata Y; Fujita M; Ohtani K; Kijima S; Kato JY
    J Biol Chem; 2000 Mar; 275(9):6337-45. PubMed ID: 10692433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
    Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
    EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
    Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
    J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
    Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR
    Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.